Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE.
Gupta K, Mehta H, Kim H, Stebbins A, Wruck LM, Muñoz D, Effron MB, Anderson RD, Pepine CJ, Jain SK, Girotra S, DeWalt DA, Whittle J, Benziger CP, Farrehi P, Zhou L, Knowlton KU, Polonsky TS, Bradley SM, Harrington RA, Rothman RL, Jones WS, Hernandez AF.
Gupta K, et al. Among authors: dewalt da.
Am Heart J. 2023 Oct;264:31-39. doi: 10.1016/j.ahj.2023.06.001. Epub 2023 Jun 7.
Am Heart J. 2023.
PMID: 37290700